Organogenesis Holdings Inc.
ORGO
$1.79
$0.031.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -924.99% | -182.10% | 469.53% | 74.90% | 44.89% |
| Total Depreciation and Amortization | -10.86% | 16.24% | 9.33% | 10.60% | 8.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 421.10% | -107.99% | 517.16% | 12.28% | -59.97% |
| Change in Net Operating Assets | 121.23% | 440.49% | -544.17% | -115.77% | -404.23% |
| Cash from Operations | 3.71% | 205.98% | 260.43% | -64.59% | -793.82% |
| Capital Expenditure | 69.76% | 13.24% | -38.41% | 13.00% | -93.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 69.76% | 13.24% | -38.41% | 13.00% | -93.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.83% | -3,352.63% | 99.52% | 82.40% | 82.79% |
| Issuance of Common Stock | -- | -- | -99.81% | 2,500.00% | -- |
| Repurchase of Common Stock | -- | -69.88% | 99.66% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4,240.97% | -883.12% | -114.29% | -508.65% | 83.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.98% | 91.29% | -27.33% | -310.45% | -3,353.67% |